glutathione huberman lab Andrew Huberman, Ph.D. (@hubermanlab) • Instagram photos and videos Developing a Rational Approach to

Potential Benefits Investigated for gastrointestinal mucosal healing: promoting repair of damaged gut lining in inflammatory bowel conditions, ulcers, and leaky gut Gastric acid stability: uniquely suited for oral delivery among therapeutic peptides because BPC-157 is a native component of gastric juice and resists acid degradation VEGF-mediated angiogenesis: promoting mucosal blood vessel formation essential for tissue repair in chronically inflamed or damaged gut tissue Investigated for inflammatory bowel disease (IBD): preclinical evidence for mucosal protection and anti-inflammatory effects in colitis models Gastroparesis support: pro-motility effects via vagal cholinergic pathways investigated in preclinical models of delayed gastric emptying Leaky gut (intestinal hyperpermeability): tight junction protein support and mucosal integrity restoration investigated in preclinical research Oral route delivers medication directly to the gut mucosa where it is most needed, without requiring injection Convenient capsule administration for daily GI protocols, suitable for patients who cannot or prefer not to self-inject Systemic tissue repair support via potential mucosal absorption at therapeutic doses (extent of systemic absorption is under investigation) May complement injectable BPC-157 protocols for patients with both GI and systemic recovery goals Speak with a physician Interested in BPC-157 (Oral)

Recommendations and limitations Based on the information reviewed, methylcobalamin appears to be the more effective and bioavailable form of vitamin B12, especially for individuals with conditions that impair absorption or methylation

Press the plunger slightly to expel air

These references provide additional scientific assist for BPC 157 capsules in lab research

SantosMCOliveiraALViegas-CrespoAMVicenteLBarreirosAMonteiroPet alSystemic markers of the redox balance in chronic obstructive pulmonary disease

These are laboratory observations, not personal-outcome predictions